Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Embolism | 53 | 2024 | 2599 | 6.610 |
Why?
|
Venous Thromboembolism | 23 | 2024 | 1883 | 2.270 |
Why?
|
Ventricular Dysfunction, Right | 5 | 2024 | 646 | 1.690 |
Why?
|
Fibrinolytic Agents | 12 | 2024 | 2080 | 1.680 |
Why?
|
Anticoagulants | 28 | 2024 | 4852 | 1.410 |
Why?
|
Acute Disease | 20 | 2024 | 7243 | 1.130 |
Why?
|
Hemorrhage | 20 | 2024 | 3467 | 0.850 |
Why?
|
Thrombolytic Therapy | 5 | 2022 | 2055 | 0.810 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2024 | 1899 | 0.770 |
Why?
|
Thromboembolism | 4 | 2024 | 1004 | 0.590 |
Why?
|
Diclofenac | 1 | 2017 | 69 | 0.570 |
Why?
|
Heparin | 3 | 2022 | 1636 | 0.560 |
Why?
|
Thrombosis | 8 | 2024 | 2957 | 0.520 |
Why?
|
Epidemiologic Studies | 1 | 2018 | 677 | 0.480 |
Why?
|
Enoxaparin | 3 | 2021 | 391 | 0.460 |
Why?
|
Vena Cava Filters | 4 | 2019 | 270 | 0.420 |
Why?
|
Venous Thrombosis | 7 | 2024 | 1323 | 0.400 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3858 | 0.390 |
Why?
|
Propensity Score | 1 | 2018 | 1969 | 0.360 |
Why?
|
Registries | 15 | 2024 | 8375 | 0.350 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3252 | 0.350 |
Why?
|
beta-Alanine | 1 | 2010 | 82 | 0.340 |
Why?
|
Recurrence | 7 | 2024 | 8509 | 0.300 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2271 | 0.290 |
Why?
|
Humans | 81 | 2024 | 768166 | 0.280 |
Why?
|
Health Status | 2 | 2020 | 4091 | 0.270 |
Why?
|
Polysomnography | 2 | 2024 | 1871 | 0.270 |
Why?
|
Sex Factors | 4 | 2021 | 10632 | 0.270 |
Why?
|
Aged | 32 | 2024 | 171504 | 0.260 |
Why?
|
Prognosis | 12 | 2023 | 30010 | 0.260 |
Why?
|
Prospective Studies | 12 | 2024 | 54926 | 0.250 |
Why?
|
Vitamin K | 3 | 2024 | 314 | 0.240 |
Why?
|
Hospitalization | 9 | 2024 | 10840 | 0.240 |
Why?
|
Benzimidazoles | 1 | 2010 | 864 | 0.240 |
Why?
|
Blood Coagulation | 1 | 2010 | 1162 | 0.230 |
Why?
|
Neoplasms | 8 | 2024 | 22371 | 0.230 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15454 | 0.220 |
Why?
|
Risk Factors | 19 | 2024 | 74944 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2024 | 10399 | 0.210 |
Why?
|
Atrial Fibrillation | 3 | 2024 | 5176 | 0.210 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2022 | 345 | 0.210 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15948 | 0.200 |
Why?
|
Middle Aged | 27 | 2024 | 223492 | 0.200 |
Why?
|
Spain | 6 | 2021 | 485 | 0.200 |
Why?
|
Fibric Acids | 1 | 2021 | 27 | 0.190 |
Why?
|
International Classification of Diseases | 2 | 2024 | 937 | 0.190 |
Why?
|
Female | 36 | 2024 | 397192 | 0.180 |
Why?
|
Antiphospholipid Syndrome | 1 | 2022 | 167 | 0.180 |
Why?
|
Niacin | 1 | 2021 | 117 | 0.180 |
Why?
|
Male | 32 | 2024 | 364719 | 0.180 |
Why?
|
Drug Administration Schedule | 3 | 2024 | 4860 | 0.180 |
Why?
|
Risk Assessment | 12 | 2024 | 24315 | 0.170 |
Why?
|
Quality of Life | 2 | 2019 | 13490 | 0.170 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 111 | 0.170 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 1942 | 0.160 |
Why?
|
Iran | 4 | 2022 | 763 | 0.150 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3115 | 0.150 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.150 |
Why?
|
Europe | 3 | 2020 | 3436 | 0.150 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2021 | 418 | 0.140 |
Why?
|
Cardiac Tamponade | 1 | 2019 | 175 | 0.140 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2017 | 87 | 0.140 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 246 | 0.140 |
Why?
|
Pericardial Effusion | 1 | 2019 | 246 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2024 | 1126 | 0.130 |
Why?
|
Risk | 3 | 2019 | 9613 | 0.130 |
Why?
|
Aged, 80 and over | 12 | 2021 | 59629 | 0.130 |
Why?
|
Ankle | 1 | 2019 | 353 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3251 | 0.130 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3706 | 0.130 |
Why?
|
Syncope | 1 | 2018 | 430 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1206 | 0.120 |
Why?
|
Foot | 1 | 2019 | 576 | 0.120 |
Why?
|
Time Factors | 4 | 2024 | 40218 | 0.120 |
Why?
|
Administration, Oral | 4 | 2024 | 4030 | 0.120 |
Why?
|
Hospital Mortality | 4 | 2021 | 5349 | 0.120 |
Why?
|
Treatment Outcome | 12 | 2023 | 65371 | 0.120 |
Why?
|
Cause of Death | 3 | 2020 | 3721 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7454 | 0.110 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2021 | 1483 | 0.100 |
Why?
|
Research Design | 3 | 2018 | 6211 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 940 | 0.100 |
Why?
|
Observer Variation | 1 | 2018 | 2622 | 0.100 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20227 | 0.100 |
Why?
|
Algorithms | 3 | 2024 | 14164 | 0.100 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 1399 | 0.100 |
Why?
|
Vaccination | 2 | 2021 | 3437 | 0.100 |
Why?
|
Catheterization | 1 | 2017 | 1430 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2020 | 2763 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6526 | 0.090 |
Why?
|
Cohort Studies | 6 | 2024 | 41754 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2596 | 0.090 |
Why?
|
Pandemics | 5 | 2022 | 8748 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3212 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39348 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14729 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1951 | 0.080 |
Why?
|
Comorbidity | 5 | 2024 | 10590 | 0.080 |
Why?
|
Vena Cava, Inferior | 2 | 2024 | 463 | 0.080 |
Why?
|
Stroke | 3 | 2022 | 9755 | 0.080 |
Why?
|
Tissue Plasminogen Activator | 1 | 2014 | 1165 | 0.080 |
Why?
|
Thrombin | 1 | 2010 | 600 | 0.070 |
Why?
|
Survival Rate | 2 | 2018 | 12840 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7951 | 0.070 |
Why?
|
Cardiology | 1 | 2018 | 1702 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3533 | 0.060 |
Why?
|
Disease Progression | 1 | 2022 | 13671 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3415 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8741 | 0.060 |
Why?
|
Intensive Care Units | 3 | 2023 | 3800 | 0.060 |
Why?
|
Databases, Factual | 4 | 2024 | 8080 | 0.060 |
Why?
|
Anxiety | 1 | 2019 | 4672 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5100 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3968 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3239 | 0.050 |
Why?
|
Thrombocytopenia | 2 | 2021 | 1179 | 0.050 |
Why?
|
Survival Analysis | 1 | 2016 | 10101 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8543 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2015 | 2194 | 0.050 |
Why?
|
Sex Characteristics | 2 | 2023 | 2650 | 0.050 |
Why?
|
Lipid Regulating Agents | 1 | 2021 | 21 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2021 | 81762 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2023 | 12465 | 0.050 |
Why?
|
Length of Stay | 3 | 2021 | 6498 | 0.050 |
Why?
|
Esters | 1 | 2021 | 212 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10873 | 0.040 |
Why?
|
Sulfhydryl Compounds | 1 | 2021 | 296 | 0.040 |
Why?
|
Incidence | 4 | 2021 | 21538 | 0.040 |
Why?
|
Patient Discharge | 2 | 2024 | 3479 | 0.040 |
Why?
|
Hypertension, Pulmonary | 1 | 2011 | 1605 | 0.040 |
Why?
|
Catheters | 1 | 2022 | 427 | 0.040 |
Why?
|
Depression | 1 | 2019 | 8230 | 0.040 |
Why?
|
Heart Failure | 2 | 2021 | 11879 | 0.040 |
Why?
|
Internationality | 1 | 2024 | 1008 | 0.040 |
Why?
|
Phlebography | 1 | 2020 | 326 | 0.040 |
Why?
|
Amides | 1 | 2021 | 451 | 0.040 |
Why?
|
Perfusion Imaging | 1 | 2020 | 195 | 0.040 |
Why?
|
Databases as Topic | 1 | 2020 | 472 | 0.040 |
Why?
|
Critical Illness | 2 | 2022 | 2756 | 0.040 |
Why?
|
Lung | 2 | 2021 | 10099 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15662 | 0.040 |
Why?
|
Home Care Services | 1 | 2024 | 659 | 0.040 |
Why?
|
Hemostasis | 1 | 2020 | 468 | 0.040 |
Why?
|
Glycosaminoglycans | 1 | 2020 | 611 | 0.040 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2018 | 102 | 0.030 |
Why?
|
Thrombocytosis | 1 | 2016 | 88 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18412 | 0.030 |
Why?
|
United States | 5 | 2023 | 73039 | 0.030 |
Why?
|
Angiography | 1 | 2021 | 1597 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2766 | 0.030 |
Why?
|
Outpatients | 1 | 2024 | 1600 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1751 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1737 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2130 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2018 | 304 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1329 | 0.030 |
Why?
|
Medicare | 2 | 2023 | 6809 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2016 | 382 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.030 |
Why?
|
Pregnancy | 3 | 2021 | 30256 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2020 | 1429 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2018 | 519 | 0.030 |
Why?
|
Thiazoles | 1 | 2020 | 1542 | 0.030 |
Why?
|
Ultrasonography | 2 | 2020 | 6004 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2024 | 2783 | 0.030 |
Why?
|
Adult | 6 | 2023 | 223646 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2227 | 0.020 |
Why?
|
International Cooperation | 1 | 2018 | 1436 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2536 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1805 | 0.020 |
Why?
|
Troponin | 1 | 2014 | 535 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22291 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10760 | 0.020 |
Why?
|
Ischemia | 1 | 2018 | 1900 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9669 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2894 | 0.020 |
Why?
|
Critical Care | 1 | 2021 | 2715 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3073 | 0.020 |
Why?
|
Anemia | 1 | 2016 | 1514 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1240 | 0.020 |
Why?
|
Lung Diseases | 1 | 2016 | 1944 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5047 | 0.020 |
Why?
|
Arteries | 1 | 2011 | 1127 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4887 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3288 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2016 | 1932 | 0.020 |
Why?
|
Models, Statistical | 1 | 2019 | 5107 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15869 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 60066 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6316 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12077 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13014 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 89169 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2015 | 3007 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26422 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36535 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20760 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42669 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9384 | 0.010 |
Why?
|
Child | 1 | 2020 | 80917 | 0.010 |
Why?
|
Animals | 1 | 2020 | 169246 | 0.000 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_